article thumbnail

Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more

GeekWire

Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. Rubinstein joined Adaptive in 2011 as senior vice president of corporate and business development and became president seven years later. Mark Adams.

article thumbnail

Seattle biotech startup Sana Biotechnology will develop 163K square-foot facility in the Bay Area

GeekWire

Sana Biotechnology , a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its new biomanufacturing facility. The gene editing and cell therapy company announced that it will develop a 163,000 square-foot manufacturing facility in Fremont, Calif. (Sana Photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Adaptive Biotechnologies lays off about 100 people, 12% of headcount, to ‘streamline our workforce’

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, the company’s chief scientific officer. Adaptive Biotechnologies Photo). Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned. “We

article thumbnail

Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

GeekWire

Sana Biotechnology has a new $50 million tool in its toolbox. Beam may also receive additional payments, for instance upon the achievement of development and sales milestones. Sana aims to develop therapeutics for conditions as diverse as cancer, diabetes and cardiovascular disorders. Sana CEO and president Steve Harr.

article thumbnail

Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle

GeekWire

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. Harlan, former head of the the computational biology program at Fred Hutch, serves as chief scientific officer.

article thumbnail

Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech

GeekWire

Lumen Bioscience today announced a $16 million Series B round to help support its novel approach to rapid and low-cost drug development. It has three clinical programs to treat gastrointestinal diseases including C. Avista Development, Columbia Pacific, and local angels also participated, along with the co-founders.

article thumbnail

Tadataka Yamada, 1945-2021: Pioneer in drug development led global health at Gates Foundation

GeekWire

Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent six years at the Bill and Melinda Gates Foundation as head of global health, died Wednesday morning of natural causes at his home in Seattle. Tadataka “Tachi” Yamada. Twitter Photo via @TachiYamada).